Diligence memo · auto-generated · as of July 2, 2026
LungLife AI, Inc.
LungLife AI, Inc. looks under-valued against its niche peers and is at-risk on financing cadence.
Businessfiled
LungLife AI, Inc. operates in AI / ML, based in THOUSAND OAKS.
Sub-sector tags: ai/ml.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
LungLife AI, Inc. has raised $68M in disclosed capital across 15 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $25M on 2015-05-20.
Most recent recorded round closed around 2024-03-22.
Valuation (modeled)modeled
Provath models LungLife AI, Inc. at approximately $2.9M (range $774K–$5.4M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.01× the median modeled value of Series B AI / ML companies in 2022–2024 (33 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 4 months.
Last raise 2.3 yr ago; this sector typically re-raises about every 11 months.
Past due for a raise versus sector cadence — watch for distress or a bridge.
The last round was 3.4× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 96% of AI / ML peers (2067 compared).
Modeled value ranks above 68% of those peers.
Closest niche peers: Black Crow AI, Inc., Arthur AI, Inc., Deep 6 AI Inc., Beacons AI Inc., Replicate, Inc..
Peoplefiled
24 named people on file across officers, directors and signatories.
Risks & flagsmixed
Overdue for a raise versus sector norm — distress or bridge risk.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.